- Home
- CUBE vs ASND Comparison
CUBE vs ASND Comparison
Compare CUBE & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBE
- ASND
- Stock Information
- Founded
- CUBE 2004
- ASND 2006
- Country
- CUBE United States
- ASND Denmark
- Employees
- CUBE N/A
- ASND N/A
- Industry
- CUBE Real Estate Investment Trusts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CUBE Real Estate
- ASND Health Care
- Exchange
- CUBE Nasdaq
- ASND Nasdaq
- Market Cap
- CUBE 8.1B
- ASND 9.1B
- IPO Year
- CUBE 2004
- ASND 2015
- Fundamental
- Price
- CUBE $42.60
- ASND $155.07
- Analyst Decision
- CUBE Buy
- ASND Strong Buy
- Analyst Count
- CUBE 13
- ASND 16
- Target Price
- CUBE $48.08
- ASND $213.88
- AVG Volume (30 Days)
- CUBE 1.9M
- ASND 587.4K
- Earning Date
- CUBE 05-01-2025
- ASND 05-01-2025
- Dividend Yield
- CUBE 4.90%
- ASND N/A
- EPS Growth
- CUBE N/A
- ASND N/A
- EPS
- CUBE 1.69
- ASND N/A
- Revenue
- CUBE $1,079,894,000.00
- ASND $398,509,511.00
- Revenue This Year
- CUBE $1.15
- ASND $62.61
- Revenue Next Year
- CUBE $3.70
- ASND $72.16
- P/E Ratio
- CUBE $25.13
- ASND N/A
- Revenue Growth
- CUBE 1.89
- ASND 12.06
- 52 Week Low
- CUBE $34.24
- ASND $111.09
- 52 Week High
- CUBE $55.14
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- CUBE 61.15
- ASND 49.35
- Support Level
- CUBE $41.74
- ASND $156.02
- Resistance Level
- CUBE $43.08
- ASND $183.00
- Average True Range (ATR)
- CUBE 0.98
- ASND 7.31
- MACD
- CUBE 0.39
- ASND -0.83
- Stochastic Oscillator
- CUBE 87.27
- ASND 21.10
About CUBE CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.